Skip to main content
Ovation Science Inc. logo

Ovation Science Inc. — Investor Relations & Filings

Ticker · OVAT ISIN · CA69016D1087 LEI · 549300A1P7L8HTTQXY56 CSE Professional, scientific and technical activities
Open in API
Filings indexed 114 across all filing types
Latest filing 2024-05-07 Regulatory Filings
Country CA Canada
Listing CSE OVAT

About Ovation Science Inc.

https://ovationscience.com/

Ovation Science Inc. is a research and development company specializing in advanced topical and transdermal product formulations. The core technology is Invisicare®, a patented, high-performance drug delivery system engineered to enhance the penetration and efficacy of active ingredients, particularly cannabis and hemp-derived cannabinoids (CBD, THC, CBN, CBG). Ovation utilizes pharmaceutical protocols to develop these formulations. Its primary business model involves licensing the Invisicare® technology and proprietary formulations to international partners for manufacturing and market distribution. The company also distributes finished topical CBD products under proprietary brands, such as the Invibe® MD wellness line and ARLO CBD Beauty anti-aging line, all leveraging the unique delivery capabilities of Invisicare®.

Recent filings

Filing Released Lang Actions
52-109FV1 - Certification of annual filings - CFO (E).pdf
Regulatory Filings Classification · 95% confidence The document is a Form 52-109FV1 Certification of Annual Filings for a Venture Issuer, signed by the CFO, certifying the review and fair presentation of the annual filings for the financial year ended December 31, 2023. It explicitly states it is a certification related to annual filings, including the AIF, annual financial statements, and annual MD&A. The document is short (3105 characters) and primarily contains officer certification statements without actual financial data or detailed financial reports. According to the Certification Rule, such officer certifications, even if referencing annual reports, should be classified as Regulatory Filings (RNS) rather than the report itself (10-K or equivalent). Therefore, the correct classification is Regulatory Filings (RNS).
2024-05-07 English
52-109FV1 - Certification of annual filings - CEO (E).pdf
Regulatory Filings Classification · 95% confidence The document is a Form 52-109FV1 Certification of Annual Filings Venture Issuer Basic Certificate signed by the CEO certifying the review and fair presentation of the annual filings for the financial year ended December 31, 2023. It explicitly states it is a certification letter and does not contain the actual annual report or financial statements. The document is short (3145 characters) and serves as an officer certification rather than the report itself. According to the Certification Rule, such documents should be classified as Regulatory Filings (RNS) rather than the Annual Report (10-K) or Management Reports (MDA).
2024-05-07 English
Annual MD&A - English.pdf
Management Reports Classification · 95% confidence The document is titled 'Management Discussion & Analysis For the years ended December 31, 2023 and 2022' and contains detailed narrative about the company's business model, agreements, product lines, and forward-looking statements. It references preparation in accordance with IFRS and includes substantive discussion of business operations and financial context. The length is substantial (15,000 characters), indicating it is not a brief announcement or certification. The content matches the typical characteristics of a Management Discussion and Analysis (MD&A) report, which provides management's detailed explanation of financial results, business trends, and outlook. Therefore, the document should be classified as a Management Reports (MDA) filing.
2024-05-07 English
Audited annual financial statements – English.pdf
Audit Report / Information Classification · 95% confidence The document is titled 'Independent Auditor's Report' and contains detailed audit opinions, basis for opinion, key audit matters, and responsibilities of management and auditors. It includes consolidated financial statements for the years ended December 31, 2023 and 2022, with comprehensive financial data such as statements of financial position, loss and comprehensive loss, changes in shareholders' equity, and cash flows. The presence of an auditor's report and full financial statements indicates this is a standalone audit report rather than a full annual report or other filing. The document length is substantial (15,000 characters), and it contains actual financial data and notes. Therefore, it fits the definition of an Audit Report / Information (AR).
2024-05-07 English
ON form 13-502F1 (class 1 and 3B reporting issuers - participation fee).PDF
Regulatory Filings Classification · 95% confidence The document is a Form 13-502F1 related to participation fees for Class 1 and Class 3B reporting issuers, submitted to the Ontario Securities Commission. It includes a management certification by the CFO, market value calculations for equity securities over quarterly periods, and fee calculations based on OSC Rule 13-502 Fees. The document is primarily a regulatory filing with officer certification and fee calculation details, not a financial report or earnings release. It does not contain substantive financial statements or detailed financial analysis but serves as a compliance and certification filing to a regulatory body. Therefore, it fits best under Regulatory Filings (RNS). The document length is under 5,000 characters, consistent with a certification and fee submission rather than a full report.
2024-05-07 English
AB form 13-501F1 (class 1 and 3B reporting issuers - participation fee).PDF
Regulatory Filings Classification · 95% confidence The document is a Form 13-501F1 Management Certification submitted to the Alberta Securities Commission. It contains a certification statement by an officer (CFO) confirming the accuracy and completeness of the information provided. The content includes market value calculations for equity securities and participation fee details. There are no financial statements, detailed financial performance data, or management discussion and analysis. The document is primarily a regulatory certification form related to reporting issuer fees, not a financial report or earnings release. It fits the criteria for a Regulatory Filing (RNS) as it is a compliance document and officer certification rather than a full report or announcement of a report.
2024-05-07 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.